Home
Products
Learn
About
Pricing
Log In
VERV
Asset Logo

VERVE THERAPEUTICS INC

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-22.31%
Annual Growth

4 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Verve Therapeutics, Inc. is a clinical-stage company. The Company is focused on developing a new class of genetic medicines for cardiovascular disease with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The Company’s lead programs include VERVE-102, VERVE-201, and VERVE-301, which target the three cholesterol drivers of atherosclerosis: LDL-C, remnant cholesterol, and Lp(a). VERVE-102 is designed to permanently turn off the PCSK9 gene in the liver and is being developed initially for heterozygous familial hypercholesterolemia (HeFH) and ultimately to treat patients with established atherosclerotic cardiovascular disease (ASCVD) who continue to be impacted by high LDL-C levels. VERVE- 201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for refractory hypercholesterolemia. VERVE-301 is designed to permanently turn off the LPA gene to reduce Lp(a) levels.

📈 Performance

Price History*

-85.62%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$4.59

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in VERV

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

93 weeks

💵 Average investment amount

$6,863

Last time a customer invested in VERV

67 days
VERV investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in VERV also invest in...

Editas Medicine Inc.

EDIT

🙌 Performance (5Yr p.a)

-18.93%

📊 Share price

$1.28 USD
Find Out More

🙌 Performance (5Yr p.a)

10.90%

📊 Share price

$87.44 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-5.29%

📊 Share price

$37.78 USD

🙌 Performance (5Yr p.a)

257.81%

📊 Share price

$101.49 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

26.08%

📊 Share price

$131.34 USD

📈 HIGH PRICE GROWTH

Want more shares? Try these...

📊 Share price

$39.25 USD

🙌 Performance (5Yr p.a)

-16.65%

📊 Share price

$0.54 USD
Compare
Add to watchlist